[go: up one dir, main page]

EE200200601A - Uus stabiilne tiasolidiindiooniderivaadi kristallja meetod selle valmistamiseks - Google Patents

Uus stabiilne tiasolidiindiooniderivaadi kristallja meetod selle valmistamiseks

Info

Publication number
EE200200601A
EE200200601A EEP200200601A EEP200200601A EE200200601A EE 200200601 A EE200200601 A EE 200200601A EE P200200601 A EEP200200601 A EE P200200601A EE P200200601 A EEP200200601 A EE P200200601A EE 200200601 A EE200200601 A EE 200200601A
Authority
EE
Estonia
Prior art keywords
preparation
stable crystalline
novel stable
thiazolidinedione derivative
derivative process
Prior art date
Application number
EEP200200601A
Other languages
English (en)
Estonian (et)
Inventor
Ohnota Michiro
Orita Kazuo
Original Assignee
Kyorin Pharmaceutical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Pharmaceutical Co., Ltd. filed Critical Kyorin Pharmaceutical Co., Ltd.
Publication of EE200200601A publication Critical patent/EE200200601A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C30CRYSTAL GROWTH
    • C30BSINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B7/00Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Metallurgy (AREA)
  • Materials Engineering (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
EEP200200601A 2000-04-25 2001-04-23 Uus stabiilne tiasolidiindiooniderivaadi kristallja meetod selle valmistamiseks EE200200601A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000124006 2000-04-25
PCT/JP2001/003450 WO2001081327A1 (en) 2000-04-25 2001-04-23 Novel stable crystal of thiazolidinedione derivative and process for producing the same

Publications (1)

Publication Number Publication Date
EE200200601A true EE200200601A (et) 2004-04-15

Family

ID=18634205

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200601A EE200200601A (et) 2000-04-25 2001-04-23 Uus stabiilne tiasolidiindiooniderivaadi kristallja meetod selle valmistamiseks

Country Status (23)

Country Link
US (1) US6770133B2 (xx)
EP (1) EP1277745A4 (xx)
KR (1) KR20030007548A (xx)
CN (1) CN1426402A (xx)
AU (1) AU4882801A (xx)
BG (1) BG107200A (xx)
BR (1) BR0110258A (xx)
CA (1) CA2407349A1 (xx)
CZ (1) CZ20023502A3 (xx)
EA (1) EA004244B1 (xx)
EE (1) EE200200601A (xx)
HK (1) HK1053835A1 (xx)
HU (1) HUP0300475A3 (xx)
IL (1) IL152224A0 (xx)
IS (1) IS6586A (xx)
MA (1) MA25664A1 (xx)
MX (1) MXPA02010545A (xx)
NO (1) NO20025069D0 (xx)
PL (1) PL365533A1 (xx)
SK (1) SK15142002A3 (xx)
WO (1) WO2001081327A1 (xx)
YU (1) YU80302A (xx)
ZA (1) ZA200208293B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001228854A1 (en) 2000-02-01 2001-08-14 Kyorin Pharmaceutical Co. Ltd. Alkali metal salt of thiazolidine-2,4-dione derivative
WO2003062214A1 (en) * 2002-01-23 2003-07-31 Kyorin Pharmaceutical Co., Ltd. Novel stable crystal of benzylthiazolidinedione derivative and method for preparation thereof
DE10308351A1 (de) 2003-02-27 2004-11-25 Aventis Pharma Deutschland Gmbh 1,3-substituierte Cycloalkylderivate mit sauren, meist heterocyclischen Gruppen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE10308353A1 (de) 2003-02-27 2004-12-02 Aventis Pharma Deutschland Gmbh Diarylcycloalkylderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE10308352A1 (de) 2003-02-27 2004-09-09 Aventis Pharma Deutschland Gmbh Arylcycloalkylderivate mit verzweigten Seitenketten, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel
US7148246B2 (en) 2003-02-27 2006-12-12 Sanofi-Aventis Deutschland Gmbh Cycloalkyl derivatives having bioisosteric carboxylic acid groups, processes for their preparation and their use as pharmaceuticals
DE10308355A1 (de) 2003-02-27 2004-12-23 Aventis Pharma Deutschland Gmbh Aryl-cycloalkyl substituierte Alkansäurederivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel
CA2546601A1 (en) 2003-11-19 2005-06-09 Metabasis Therapeutics, Inc. Novel phosphorus-containing thyromimetics
EP1586573B1 (en) 2004-04-01 2007-02-07 Sanofi-Aventis Deutschland GmbH Oxadiazolones, processes for their preparation and their use as pharmaceuticals
DE102005026762A1 (de) 2005-06-09 2006-12-21 Sanofi-Aventis Deutschland Gmbh Azolopyridin-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen
TWI383008B (zh) * 2005-08-17 2013-01-21 Nippon Catalytic Chem Ind 吸水性樹脂之製造方法及吸水性樹脂以及其利用
TW200838512A (en) 2007-02-08 2008-10-01 Daiichi Sankyo Co Ltd Crystalline forms of a thiazolidinedione compound and manufacturing methods thereof
US20120046364A1 (en) 2009-02-10 2012-02-23 Metabasis Therapeutics, Inc. Novel Sulfonic Acid-Containing Thyromimetics, and Methods for Their Use

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4864028A (en) * 1983-09-14 1989-09-05 Alcon Laboratories, Inc. Spiro-tricyclicaromatic succinimide derivatives
CN1003445B (zh) * 1984-10-03 1989-03-01 武田药品工业株式会社 噻唑烷二酮衍生物,其制备方法和用途
AR240698A1 (es) * 1985-01-19 1990-09-28 Takeda Chemical Industries Ltd Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales
JP3053490B2 (ja) 1991-02-25 2000-06-19 杏林製薬株式会社 チアゾリジン−2,4−ジオン誘導体とその塩及び製造法
JPH04270273A (ja) 1991-02-25 1992-09-25 Kyorin Pharmaceut Co Ltd チアゾリジン−2,4−ジオン誘導体とその塩及びその製造法
JP3644998B2 (ja) 1995-02-09 2005-05-11 塩野義製薬株式会社 ベンジリデン誘導体の結晶の選択的取得方法
US6001862A (en) * 1995-06-02 1999-12-14 Kyorin Pharameuticals Co., Ltd. N-benzyldioxothiazolidylbenzamide derivatives and processes for preparing the same
JP3144624B2 (ja) * 1995-06-02 2001-03-12 杏林製薬株式会社 N−ベンジルジオキソチアゾリジルベンズアミド誘導体及びその製造法
US6147101A (en) * 1995-06-02 2000-11-14 Kyorin Pharmaceutical Co., Ltd. N-benzyldioxothiazolidylbenzamide derivatives and process for producing the same
JPH101476A (ja) 1996-02-28 1998-01-06 Nissan Chem Ind Ltd 効力が向上したチフルザミド
ZA971637B (en) * 1996-02-28 1997-09-25 Nissan Chemical Ind Ltd Thifluzamide with improved efficacy.
GB9726566D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical

Also Published As

Publication number Publication date
EP1277745A1 (en) 2003-01-22
IS6586A (is) 2002-10-21
HUP0300475A3 (en) 2004-10-28
EA004244B1 (ru) 2004-02-26
IL152224A0 (en) 2003-05-29
WO2001081327A1 (en) 2001-11-01
EP1277745A4 (en) 2004-09-15
ZA200208293B (en) 2003-10-06
US6770133B2 (en) 2004-08-03
AU4882801A (en) 2001-11-07
NO20025069L (no) 2002-10-22
SK15142002A3 (sk) 2003-04-01
MXPA02010545A (es) 2004-05-14
HUP0300475A2 (hu) 2003-06-28
CA2407349A1 (en) 2002-10-24
KR20030007548A (ko) 2003-01-23
EA200201055A1 (ru) 2003-06-26
BR0110258A (pt) 2003-01-07
BG107200A (bg) 2003-11-28
HK1053835A1 (en) 2003-11-07
CZ20023502A3 (cs) 2003-06-18
MA25664A1 (fr) 2002-12-31
PL365533A1 (en) 2005-01-10
NO20025069D0 (no) 2002-10-22
US20030101925A1 (en) 2003-06-05
CN1426402A (zh) 2003-06-25
YU80302A (sh) 2005-11-28

Similar Documents

Publication Publication Date Title
NO20025978L (no) Benzotiazol-derivater
EE200300171A (et) Kristalliline monohüdraat, meetodid selle valmistamiseks ja selle kasutamine farmatseutilise kompositsiooni valmistamiseks
EE200200601A (et) Uus stabiilne tiasolidiindiooniderivaadi kristallja meetod selle valmistamiseks
NO20032518L (no) Fremgangsmåte for fremstilling av amlodipinmaleat
NO20020030L (no) Krystallinske 1-metylkarbapenemforbindelser
DK1272489T3 (da) Fremgangsmåde til præparation af cabergolins krystallinske form I
EE200300255A (et) Asitromütsiin monohüdraadina, selle valmistamismeetod ja selle kasutamine ravimkoostises
AU2001292285A1 (en) Thiazole or oxazole derivatives
EE200200544A (et) Kabergoliini kristallvorm II, meetod selle valmistamiseks ning seda sisaldav farmatseutiline kompositsioon
NO20016237D0 (no) Fremgangsmåte for tilpasning av aromablandinger
DE10196082T1 (de) FLIP-CHIP-Montageverfahren
EE200100615A (et) Mikrograanul, selle valmistamismeetod ja farmatseutiline preparaat
DE60130137D1 (de) Kristallisationsverfahren
DK1231211T3 (da) Thiazolidindion-derivater som antidiabetika
AR027952A1 (es) Compuesto ceclico
EE200200637A (et) Torasemiidi uudne polümorf V, selle valmistamismeetod, kasutamine ja ravimvorm
NO20024464D0 (no) Amorf Torasemide-modifikasjon
EE200200385A (et) Alfa-(2,4-disulfofenüül)-N-tert-butüülnitrooni jaselle farmatseutiliselt vastuvõetavate soolade uus valmistamise meetod
NO20024887L (no) FremgangsmÕte for fremstilling av benzokondenserte heterosykliske forbindelser
EE200300045A (et) Kristalne ravimaine
EE200300204A (et) Meetod distamütsiini derivaadi valmistamiseks
NO20024679L (no) Krystallinsk farmasöytikum
GB0004365D0 (en) Preparation method for oxazoline compounds
NO20023687D0 (no) 1,3,4-oksadiazolderivater og fremgangsmåte for fremstilling derav
NO20030626D0 (no) Faststoff preparat med höy absorpsjonsevne